In NOD mice, as with IBD and MS, SCFAs, notably butyrate, decreased the incidence and severity of diabetes with reduced frequency of autoimmune CD8+ T cells and B cells and increased Tregs and IL-10 production (120). This evidence concerns the gene IL10 and myeloid sarcoma.